“…This evidence supports the idea that a deficiency of this cell subset may be a possible factor in susceptibility to RA [42]. This hypothesis seems to be further supported by investigations of the correlation between the percentage of Treg cells in PB and disease duration, which have confirmed higher numbers of circulating Treg cells in patients with long-standing disease [35,39]. Moreover, in established disease, where proinflammatory cytokines, including TNFα, are present at high levels in PB and target organs, FoxP3 expression within the CD4 + CD25 + cell population seems to be reduced, giving rise to the hypothesis that proinflammatory molecules play a role in inducing an abnormal Treg cell phenotype [37,40].…”